FIELD: medicine.
SUBSTANCE: to correct osteoporosis and prevent osteoporotic fractures osteoporosis shall be simulated by means of bilateral ovariotomy. Then female Wistar rats are intragastically fed with enalapril of 0.5 mg/kg once a day every day within 8 weeks after ovariotomy. Osteoprotective enalapril action is estimated with respect to microcirculation in bone tissue and width of trabecula of bone.
EFFECT: osteoporosis retardation under hypoestrogenic condition, prevention of osteoporotic fractures owing to increased bone tissue perfusion.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OSTEOPOROSIS CORRECTION AND PREVENTION OF OSTEOPOROTIC FRACTURES BY MEANS OF LOSARTAN | 2008 |
|
RU2369391C1 |
METHOD FOR RESERVATROL AND ENALAPRIL BASED OSTEOPOROSIS CORRECTION AND FRAGILITY FRACTURE PREVENTION | 2010 |
|
RU2437160C1 |
METHOD FOR THE CORRECTION OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES WITH 3-HYDROXY-2-ETHYL-6-METHYLPYRIDINIUM NICOTINATE IN EXPERIMENT | 2021 |
|
RU2763011C1 |
METHOD FOR RESERVATROL-BASED OSTEOPOROSIS CORRECTION AND FRAGILITY FRACTURE PREVENTION | 2010 |
|
RU2437161C1 |
METHOD FOR ROSUVASTATIN CORRECTION OF BONE MICROCIRCULATION IN EXPERIMENTAL OSTEOPOROSIS AND ACCOMPANYING FRACTURES | 2013 |
|
RU2538612C1 |
METHOD FOR CORRECTING BONE MICROCIRCULATION ACCOMPANYING EXPERIMENTALOSTEOPOROSIS AND UNDERLYING FRACTURES WITH USE OF COMBINATION OF L-ARGININE AND ENALAPRIL | 2013 |
|
RU2542424C1 |
METHOD FOR CORRECTION OF BONE TISSUE MICROCIRCULATON IN EXPERIMENTAL OSTEOPOROSIS AND ASSOCIATED FRACTURES WITH COMBINATION OF RECOMBINANT ERYTHROPOIETIN AND ROSUVASTATIN | 2013 |
|
RU2541184C1 |
METHOD FOR CORRECTING OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES WITH 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM HYDROXYBUTANEDIOATE IN EXPERIMENT | 2021 |
|
RU2775439C1 |
METHOD FOR CORRECTING BONE MICROCIRCULATION ACCOMPANYING OSTEOPOROSIS AND UNDERLYING FRACTURES WITH USE OF COMBINATION OF L-ARGININE AND LOSARTAN | 2013 |
|
RU2542425C1 |
METHOD OF CORRECTING MICROCIRCULATION IN BONE TISSUE WITH COMBINATION OF L-NORVALIN AND ROSUVASTATIN IN CASE OF EXPERIMENTAL OSTEOPOROSIS AND FRACTURES AT ITS BACKGROUND | 2013 |
|
RU2540927C1 |
Authors
Dates
2009-10-10—Published
2008-06-02—Filed